Univariate and multivariate logistic models of medication exposure between long COVID cases and controls with duration of COVID as a covariate.

<p>Model 1: univariate; Model 2: adjusted for COVID duration; Model 3: adjusted for duration, sex, and age group; Model 4: adjusted for COVID duration, sex, age group, and region; Model 5: adjusted for duration, sex, age group, region, and CCI; Model 6: adjusted for COVID duration, sex, age group, region, CCI, and underlying comorbidities. <sup>1</sup>Day of COVID diagnosis to 14 days later. <sup>2</sup>15 days since COVID diagnosis to end of follow-up (diagnosis of long COVID, diagnosis of other COVID episodes, or end of observation period). *<i>p</i> < 0.05; **<i>p</i> < 0.01; ***<i>p</i> < 0.001. APAP, acetaminophen or paracetamol; CCI, Charlson Comorbidity Index; CI, confidence interval; NSAIDs, nonsteroidal anti-inflammatory drugs; OR, odds ratio.</p> <p>(DOCX)</p>